These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

451 related items for PubMed ID: 22914208

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Local ultra-low-dose estriol gel treatment of vulvo-vaginal atrophy: efficacy and safety of long-term treatment.
    Villa P, Tagliaferri V, Amar ID, Cipolla C, Ingravalle F, Scambia G, Ricciardi W, Lanzone A.
    Gynecol Endocrinol; 2020 Jun; 36(6):535-539. PubMed ID: 31847628
    [Abstract] [Full Text] [Related]

  • 4. Quality of life and sexual function of naturally postmenopausal women on an ultralow-concentration estriol vaginal gel.
    Caruso S, Cianci S, Amore FF, Ventura B, Bambili E, Spadola S, Cianci A.
    Menopause; 2016 Jan; 23(1):47-54. PubMed ID: 26079974
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Low-dose, vaginally administered estrogens may enhance local benefits of systemic therapy in the treatment of urogenital atrophy in postmenopausal women on hormone therapy.
    Palacios S, Castelo-Branco C, Cancelo MJ, Vázquez F.
    Maturitas; 2005 Feb 14; 50(2):98-104. PubMed ID: 15653006
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Does vaginal estriol make urodynamic changes in women with overactive bladder syndrome and genitourinary syndrome of menopause?
    Matarazzo MG, Caruso S, Giunta G, Valenti G, Sarpietro G, Cianci A.
    Eur J Obstet Gynecol Reprod Biol; 2018 Mar 14; 222():75-79. PubMed ID: 29367168
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics and preliminary efficacy of two vaginal gel formulations of ultra-low-dose estriol in postmenopausal women.
    Delgado JL, Estevez J, Radicioni M, Loprete L, Moscoso Del Prado J, Nieto Magro C.
    Climacteric; 2016 Apr 14; 19(2):172-80. PubMed ID: 26786399
    [Abstract] [Full Text] [Related]

  • 11. Coital pain in the elderly: could a low dose estriol gel thrill the vulvar vestibule?
    Murina F, Graziottin A, Felice R, Di Francesco S.
    Eur J Obstet Gynecol Reprod Biol; 2016 Dec 14; 207():121-124. PubMed ID: 27838536
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of ultra-low dose 0.005% estriol vaginal gel for the treatment of vulvovaginal atrophy in postmenopausal women with early breast cancer treated with nonsteroidal aromatase inhibitors: a phase II, randomized, double-blind, placebo-controlled trial.
    Hirschberg AL, Sánchez-Rovira P, Presa-Lorite J, Campos-Delgado M, Gil-Gil M, Lidbrink E, Suárez-Almarza J, Nieto-Magro C.
    Menopause; 2020 May 14; 27(5):526-534. PubMed ID: 32049923
    [Abstract] [Full Text] [Related]

  • 14. Effects of Glycine max (L.) Merr. soy isoflavone vaginal gel on epithelium morphology and estrogen receptor expression in postmenopausal women: a 12-week, randomized, double-blind, placebo-controlled trial.
    Lima SM, Bernardo BF, Yamada SS, Reis BF, da Silva GM, Galvão MA.
    Maturitas; 2014 Jul 14; 78(3):205-11. PubMed ID: 24856055
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of raloxifene on sexual function in postmenopausal women.
    Kessel B, Nachtigall L, Plouffe L, Siddhanti S, Rosen A, Parsons A.
    Climacteric; 2003 Sep 14; 6(3):248-56. PubMed ID: 14567773
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effective treatment of vaginal atrophy with an ultra-low-dose estradiol vaginal tablet.
    Simon J, Nachtigall L, Gut R, Lang E, Archer DF, Utian W.
    Obstet Gynecol; 2008 Nov 14; 112(5):1053-60. PubMed ID: 18978105
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Efficacy of vaginally applied estrogen, testosterone, or polyacrylic acid on vaginal atrophy: a randomized controlled trial.
    Fernandes T, Costa-Paiva LH, Pedro AO, Baccaro LF, Pinto-Neto AM.
    Menopause; 2016 Jul 14; 23(7):792-8. PubMed ID: 27116462
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.